Clinical Trials Directory

Trials / Completed

CompletedNCT03181321

The First Twenty for Volunteer Firefighters

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
419 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the efficacy of an internet-based firefighter health and wellness program for volunteer fire departments.

Detailed description

A national sample of volunteer fire departments will be recruited for a 6 month, CRCT with a cross-over treatment design to determine the efficacy of The First Twenty (TF20), a wellness program focused on nutrition and fitness for firefighters. Modifications to the existing TF20 will be made to enhance the health coaching features and include tools for program evaluation. Study outcomes (changes in weight, BMI, body fat percentage, waist circumference, dietary intakes, blood pressure, and fitness activities) will be assessed pre- and post-intervention. This will be the first internet-based, occupationally tailored health and wellness program implemented for the volunteer fire service. TF20 will be an essential cost effective tool to address the epidemic of unhealthy body composition, nutrition and fitness among firefighters.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThe First TwentyThe TF20 incorporates individual goal setting and health coaching, leveraging cultural aspects of the fire service and group cohesion to motivate behavior change. The TF20 focuses on the unique needs of FF with culturally relevant nutrition and fitness strategies. TF20 was primarily designed as a cost-effective, stand-alone program for departments which have no health promotion initiative. Program components include practical approaches to nutrition, fitness and mental health.

Timeline

Start date
2014-11-01
Primary completion
2017-06-01
Completion
2018-04-30
First posted
2017-06-08
Last updated
2018-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03181321. Inclusion in this directory is not an endorsement.